Funding scheme detail

Homepage > Scheme detail
Reports name /title Funding scheme detail
Report was generated on 28 May 2024 (Date based on PCT time)
Report url http://funding.venturecenter.co.in/viewrecord.php?srn=BI20220204021006
Description & notes (A) - Technology Development Funds; (B) - Patent Protection Funds; (C) - Technology In-Licensing Funds; (D) - Technology Scale-up/ Validation / De-risking Funds; (E) - Market Entry Funds; (F) - Expansion Funds;
Seed Fund
OrganizationCombating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X)
Source of funding
SchemeSeed Fund
Type of fundingOther
Funding Amount0
Description
Range of fundingUndefined
Target investeesEntrepreneurs
NoteCombating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is a global non-profit partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria. With up to US$480 million to invest in 2016-22, CARB-X funds the best science from around the world. The CARB-X portfolio is the world’s largest early development pipeline of new antibiotics, vaccines, rapid diagnostics and other products to prevent, diagnose and treat life-threatening bacterial infections.
PurposeAccelerate a diverse portfolio of innovative antibacterial products towards clinical development and regulatory approval with funding, expert support and cross-project initiatives. We focus on the dangerous bacteria identified by the WHO and CDC priority lists.
Focus areaBiotechnology/ Biomedical/ Health Technologies
Provides Funds For A, B, C, D,
Scheme TypeOngoing scheme
Recommended scheme
Scheme statusLive scheme
More detail..Link